In particular, T cells that produce pro-inflammatory cytokines such as interferon gamma (IFN-γ) and interleukin (IL)-17 play a critical role in multiple sclerosis pathogenesis [1–8], and reduced levels of these effector molecules are associated with better therapeutic responses [9–11]. This evidence concerns the gene IFNG and multiple sclerosis.